These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11050076

  • 41. Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog.
    Matsuura B, Dong M, Coulie B, Pinon DI, Miller LJ.
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1101-8. PubMed ID: 15677347
    [Abstract] [Full Text] [Related]

  • 42. Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
    Harikumar KG, Lam PC, Dong M, Sexton PM, Abagyan R, Miller LJ.
    J Biol Chem; 2007 Nov 09; 282(45):32834-43. PubMed ID: 17827151
    [Abstract] [Full Text] [Related]

  • 43. Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.
    Miller LJ, Chen Q, Lam PC, Pinon DI, Sexton PM, Abagyan R, Dong M.
    J Biol Chem; 2011 May 06; 286(18):15895-907. PubMed ID: 21454562
    [Abstract] [Full Text] [Related]

  • 44. Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies.
    Ding XQ, Miller LJ.
    Peptides; 2001 Aug 06; 22(8):1223-8. PubMed ID: 11457514
    [Abstract] [Full Text] [Related]

  • 45. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, Behrendt R, Moroder L, Bignon E, Silvente-Poirot S, Pradayrol L, Fourmy D.
    J Biol Chem; 2002 Mar 01; 277(9):7546-55. PubMed ID: 11724786
    [Abstract] [Full Text] [Related]

  • 46. Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
    Dong M, Lam PC, Orry A, Sexton PM, Christopoulos A, Abagyan R, Miller LJ.
    J Biol Chem; 2016 Mar 04; 291(10):5172-84. PubMed ID: 26740626
    [Abstract] [Full Text] [Related]

  • 47. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
    Ceraudo E, Hierso R, Tan YV, Murail S, Rouyer-Fessard C, Nicole P, Robert JC, Jamin N, Neumann JM, Robberecht P, Laburthe M, Couvineau A.
    FASEB J; 2012 May 04; 26(5):2060-71. PubMed ID: 22291440
    [Abstract] [Full Text] [Related]

  • 48. Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification.
    Gimpl G, Anders J, Thiele C, Fahrenholz F.
    Eur J Biochem; 1996 May 01; 237(3):768-77. PubMed ID: 8647124
    [Abstract] [Full Text] [Related]

  • 49. Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking.
    Go WY, Holicky EL, Hadac EM, Rao RV, Miller LJ.
    Am J Physiol; 1998 Jul 01; 275(1):G56-62. PubMed ID: 9655684
    [Abstract] [Full Text] [Related]

  • 50. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor.
    Giragossian C, Mierke DF.
    Biochemistry; 2001 Apr 03; 40(13):3804-9. PubMed ID: 11300760
    [Abstract] [Full Text] [Related]

  • 51. Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling.
    Dong M, Wang Y, Miller LJ.
    Ann N Y Acad Sci; 2000 Apr 03; 921():381-6. PubMed ID: 11193860
    [Abstract] [Full Text] [Related]

  • 52. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 03; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

  • 53. Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP.
    Tan YV, Couvineau A, Laburthe M.
    J Biol Chem; 2004 Sep 10; 279(37):38889-94. PubMed ID: 15247290
    [Abstract] [Full Text] [Related]

  • 54. Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure.
    Boucard AA, Wilkes BC, Laporte SA, Escher E, Guillemette G, Leduc R.
    Biochemistry; 2000 Aug 15; 39(32):9662-70. PubMed ID: 10933782
    [Abstract] [Full Text] [Related]

  • 55. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin.
    Gigoux V, Escrieut C, Fehrentz JA, Poirot S, Maigret B, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy D.
    J Biol Chem; 1999 Jul 16; 274(29):20457-64. PubMed ID: 10400673
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor.
    Dong M, Pinon DI, Cox RF, Miller LJ.
    J Biol Chem; 2004 Jan 09; 279(2):1167-75. PubMed ID: 14583624
    [Abstract] [Full Text] [Related]

  • 58. Role of lysine187 within the second extracellular loop of the type A cholecystokinin receptor in agonist-induced activation. Use of complementary charge-reversal mutagenesis to define a functionally important interdomain interaction.
    Dong M, Ding XQ, Thomas SE, Gao F, Lam PC, Abagyan R, Miller LJ.
    Biochemistry; 2007 Apr 17; 46(15):4522-31. PubMed ID: 17381074
    [Abstract] [Full Text] [Related]

  • 59. The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of crosslinkable and photolabile probes.
    Klueppelberg UG, Powers SP, Miller LJ.
    Receptor; 2007 Apr 17; 1(1-2):1-11. PubMed ID: 2152369
    [Abstract] [Full Text] [Related]

  • 60. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F, Pratt DS, Wu MJ, Kolakowski LF, Beinborn M, Kopin AS.
    Mol Pharmacol; 1996 Aug 17; 50(2):436-41. PubMed ID: 8700154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.